Nomenclature for Factors of the HLA System, 1998
Julia G. Bodmer
Imperial Cancer Research Fund, Oxford, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorSteven G.E. Marsh
Rapporteur and data Coordinator
Anthony Nolan Research Institute, London, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorEkkehard D. Albert
Chairman
Policlinic for Children, University of Munich, Germany
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorWalter F. Bodmer
Rapporteur
Imperial Cancer Research Fund, Oxford, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorRonald E. Bontrop
Biomedical Primate Research Centre, Rijswijk, The Netherlands
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorBo Dupont
Sloan-Kettering Institute for Cancer Research, New York, N.Y., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorHenry A. Erlich
Roche Molecular Systems, Alameda, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorJohn A. Hansen
Fred Hutchinson Cancer Center, Seattle, Wash., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorBernard Mach
University of Geneva, Geneva, Switzerland
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorWolfgang R. Mayr
University of Vienna, Vienna, Austria
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorPeter Parham
Stanford University School of Medicine, Stanford, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorEffie W. Petersdorf
Fred Hutchinson Cancer Center, Seattle, Wash., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorTakehiko Sasazuki
Kyushu University, Fukuoka, Japan
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorGeziena M. Th. Schreuder
Leiden University Medical Center, Leiden, The Netherlands
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorJack L. Strominger
Harvard University, Cambridge, Mass., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorArne Svejgaard
State University Hospital, Copenhagen, Denmark
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorPaul I. Terasaki
University of California, Los Angeles, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorJulia G. Bodmer
Imperial Cancer Research Fund, Oxford, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorSteven G.E. Marsh
Rapporteur and data Coordinator
Anthony Nolan Research Institute, London, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorEkkehard D. Albert
Chairman
Policlinic for Children, University of Munich, Germany
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorWalter F. Bodmer
Rapporteur
Imperial Cancer Research Fund, Oxford, UK
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorRonald E. Bontrop
Biomedical Primate Research Centre, Rijswijk, The Netherlands
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorBo Dupont
Sloan-Kettering Institute for Cancer Research, New York, N.Y., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorHenry A. Erlich
Roche Molecular Systems, Alameda, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorJohn A. Hansen
Fred Hutchinson Cancer Center, Seattle, Wash., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorBernard Mach
University of Geneva, Geneva, Switzerland
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorWolfgang R. Mayr
University of Vienna, Vienna, Austria
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorPeter Parham
Stanford University School of Medicine, Stanford, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorEffie W. Petersdorf
Fred Hutchinson Cancer Center, Seattle, Wash., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorTakehiko Sasazuki
Kyushu University, Fukuoka, Japan
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorGeziena M. Th. Schreuder
Leiden University Medical Center, Leiden, The Netherlands
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorJack L. Strominger
Harvard University, Cambridge, Mass., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorArne Svejgaard
State University Hospital, Copenhagen, Denmark
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorPaul I. Terasaki
University of California, Los Angeles, Calif., USA
1 Members attending the committee meeting in October 1998.
Search for more papers by this authorDr. Julia G. Bodmer, ICRF Cancer and Immunogenetics Laboratory, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS (UK), Tel. +44 1865 222361, Fax +44 1865 222384, E-Mail [email protected]
Anthony Nolan Research Institute, Royal Free Hospital, Pond STreet, Hampstead, London NW3 2QG (UK), Tel. +44 171 284 8321, Fax +44 171 284 8331, E-Mail [email protected] Web www.anthonynolan.org.uk; www.ebi.ac.uk/imgt/hla
(For affiliations see Appendix.)
References
- 1 WHO Nomenclature Committe: Bull WHO 1968; 39: 483.
- 2 WHO Nomenclature Committe: WHO terminology report; in PI Terasaki (ed): Histocompatibility Testing, 1970. Copennagen , Munksgaard, 1970.
- 3 WHO Nomenclature Committe: Bull WHO 1972; 47: 659.
- 4 WHO Nomenclature Committe: Bull WHO 1975; 52: 261.
- 5 WHO Nomenclature Committe: Bull WHO 1978; 56: 461.
- 6 WHO Nemenclature Committee; in PI Terasaki (ed): Histocompatibility Testing, 1980. Los Angeles , UCLA Tissue Typing Laboratory, 1980, pp 18–20.
- 7 WHO Nomenclature Committee: Nomenclature for factors of the HLA system, 1984; in ED Albert, MP Baur (eds): Histocompatibility Testing, 1984. Berlin , Springer, 1985, pp 4–8.
- 8
Bodmer WF,
Albert E,
Bodmer JG,
Dupont B,
Mach B,
Mayr WR,
Sasazuki T,
Schreuder GMT,
Svejgaard A,
Terasaki PI: Nomenclature for factors of the HLA system, 1987; in
B Dupont (ed): Immunobiology of HLA.
New York
, Springer, 1989; pp
72–79.
10.1007/978-1-4612-3552-1_14 Google Scholar
- 9 Bodmer JG, Marsh SGE, Parham P, Erlich HA, Albert E, Bodmer WF, Dupont B, Mach B, Mayr WR, Sasasuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1989. Tissue Antigens 1990; 35: 1–8.
- 10 Bodmer JG, Marsh SGE, Albert E, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasasuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1990. Tissue Antigens 1991; 37: 97–104.
- 11 Bodmer JG, Marsh SGE, Albert E, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasauki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1991; in T Tsuji, M Aizawa, T Sasazuki (eds): HLA 1991. Oxford , Oxford University Press, 1992, pp 17–31.
- 12 Bodmer JG, Marsh SGE, Albert E, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasasuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1994. Tissue Antigens 1994; 44: 1–18.
- 13 Bodmer JG, Marsh SGE, Albert E, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasasuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995; 46: 1–18.
- 14 Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasasuki T, Schreuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997; 49: 297–321.
- 15 White JA, McAlpine PJ, Antonarakis S, Cann H, Eppig JT, Frazer K, Frezal J, Lancet D, Nahmias J, Pearson P, Peters J, Scott A, Scott H, Spurr N, Talbot C, Povey S: Guidelines for human gene nomenclature. Genomics 1997; 45: 468–471.
- 16 Human Genome Nomenclature Committee. www.gene.ucl.ac.uk/nomenclature/
- 17 Hurley CK, Schreuder GMT, Marsh SGE, Lau M, Middleton D, Noreen H: The search for HLA-matched donors: A summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 1997; 50: 401–418.
- 18 Robinson J, Bodmer JG, Malik A, Marsh SGE: Development of the International Immunogenetics HLA Database. Hum Immunol 1998; 59: 1–17.
- 19 IMGT/HLA Database. www.ebi.ac.uk/imgt/hla/
- 20 Robinson J, Marsh SGE, Bodmer JG: The IMGT/HLA Database. Eur J Immunogenet 1999; 26: 75.
- 21 Bahram S, Bresnahan M, Geraghty DE, Spies T: A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91: 6259–6263.
- 22 Leelayuwat C, Townend DC, Degli-Esposti MA, Abraham LJ, Dawkins RL: A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics 1994; 40: 339–351.
- 23 Laforet M, Froelich N, Parissiadis A, Pfeiffer B, Schell A, Faller B, Woehl-Jaegle M-L, Cazenave J-P, Tongio M-M: A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. Tissue Antigens 1997; 50: 347–350.
- 24 Scheltinga SA, Johnson-Dow LA, White CB, van der Zwan A-W, Bakema JE, Rozemuller EH, van den Tweel JG, Kronick M, Tilanus MGJ: A generic sequencing based typing approach for the identification of HLA-A diversity. Hum Immunol 1997; 57: 120–128.
- 25 Fischer GF, Fáe E, Frey E, Mayr WR: HLA-A*02172 adds to the heterogeneity of HLA-A*02 alleles. Tissue Antigens 1998; 51: 312–314.
- 26 Fleischhauer K, Zino E, Arevalo-Herrera M, Herrara S, Valmori D, Cerottini J-C, Benazzi E, Bordignon C, Romero P: Differential expression of HLA-A*02 subtypes in Colombian Blacks and Mestizos. Tissue Antigens 1998; 51: 204–209.
- 27 Guttridge MG, Street J, Thomas M, Darke C: Identification of HLA-A*0224: Implications for PCR-SSP HLA typing. Tissue Antigens 1999; 53: 190–193.
- 28 Hurley CK, Steiner N, Kosman C, Mitton W, Koester R, Bei M, Bush J, McCormack J, Hahn A, Henson V, Hoyer R, Wade JA, Hartzman RJ, Ng J: Novel HLA-A and -B alleles. Tissue Antigens 1998; 52: 84–87.
- 29 Ellexson ME, Peck RL, Stewart D, Keller J, Hildebrand WH: Characterisation of an HLA-A26 serologic variant. Immunogenetics 1998; 48: 152–155.
- 30 Szmania S, Baxter-Lowe LA: Corrected nucleotide sequences for HLA-A*2901 and HLA-A*3301. Tissue Antigens 1997; 50: 205–206.
- 31 Vargas-Alarcón G, Martinez-Laso J, Gomez-Casada E, Perez-Blas M, Granados J, Alegre R, Alvarez M, Zuñiga J, Arnaiz-Villena A: Description of HLA-A*6803 and A*68N in Mazatecan Indians from Mexico. Immunogenetics 1997; 46: 446–447.
- 32 Curran MD, Williams F, Little A-M, Rima BK, Madrigal JA, Middleton D: Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 1999; 53: 244–245.
- 33 del Carmen Theiler G, Marcos CY, Lindel N, Capucchio M, Schettini J, Vilches C, Gorodezky C, Stastny P, Fernandez-Vina M, Satz ML: Complete sequence of HLA-B*1522: A class I allele that types by serology as HLA-B35. Tissue Antigens 1997; 50: 311–314.
- 34 Santos S, Balas A, García-Sánchez F, Lillo R, Merino JL, Vicario JL: Complete coding sequence of a serologically undefined HLA-B antigen:HLA-B*1537. Immunogenetics 1998; 47: 501–502.
- 35 Lee KW, Steiner N, Hurley CK: Characterization of an HLA-B62 variant (B*1538) exhibiting an additional B52 serologic reactivity. Tissue Antigens 1997; 50: 662–664.
- 36 Olivo-Diaz A, Gomez-Casado E, Martinez-Laso J, Gorodezky C, Longas J, Gonzalez-Hevilla M, Alvarez M, Arnaiz-Villena A: A new HLA-B15 allele (B*15MZH) found in a Mexican from Mazahua descent. Immunogenetics 1998; 48: 148–151.
- 37 Balas A, García-Sánchez F, Santos S, Lillo R, Merino JL, Vicario JL: Characterization of a new HLA-B18 allele, B*1806 which lacks expression of the Bw6 epitope. Tissue Antigens 1998; 52: 579–582.
- 38 Seurynck K, Baxter-Lowe L-A: Novel polymorphism detected in exon 1 of HLA-B*2713. Tissue Antigens 1998; 52: 187–189.
- 39 Guttridge MG, Thompson J, Street J, Darke C: Identification, sequencing and serology of HLA-B*3527. Tissue Antigens, in press.
- 40 Steiner N, Ng J, Bush J, Hartzman RJ, Johnston-Dow L, Hurley CK: HLA-B alleles associated with the B15 serologically defined antigens. Hum Immunol 1997; 56: 84–93.
- 41 Balas A, Santos S, Garcia-Sánchez F, Lillo R, Merino JL, Vicario JL: Characterization of a new HLA-B*38 allele (B*3803) in a Spanish Caucasian individual which is closely related to the Oriental B*38021 and B*39021 alleles. Tissue Antigens, in press.
- 42 Maertens R, De Canck I, Moraes ME, Van de Casteele N, Van Reybroeck G, Vanderborght B, Moraes JR, Rossau R: Characterisation of a new HLA-B39 allele, B*3913, in a Brazilian Caucasian. Tissue Antigens 1998; 52: 583–586.
- 43 Vargas-Alarcón G, Gómez-Casado E, Martinez-Laso J, Granadas J, Garcia de la Torre C, Alegre R, Alcocer-Varela J, Arnaiz-Villena A: Description of a new HLA-B40 allele (B*4011) found in a Mexican individual of Nahua (Aztec) descent. Immunogenetics 1997; 46: 359–360.
- 44 Lardy NM, Otting N, van de Weerd J, van der Horst AR, de Waal LP, Bontrop RE: Full-length cDNA nucleotide sequence of the HLA-B*4202 allele. Tissue Antigens 1997; 50: 83–84.
- 45 Balas A, Santos S, Garcia-Sanchez F, Lillo R, Merino JL, Vicario JL: Characterization and distribution of HLA-B*5002 in a Spanish population sample. Tissue Antigens 1998; 52: 183–186.
- 46 Darke C, Guttridge MG, Thompson J, Street J, Thomas M: Molecular, serological and population studies on a novel HLA-B allele – HLA-B*5002. Tissue Antigens 1998; 51: 666–670.
- 47 Poli F, Bianchi P, Crespiatico L, Scalamogna M, Bredi E, Sirchia G: Identification of HLA-B*5108 using PCR-SSP, PCR-SSOP and sequencing. Tissue Antigens 1997; 50: 202–204.
- 48 Iwanaga KK, Eberle M, Kolman CJ, Bermingham E, Watkins DI: Further diversification of the HLA-B locus in Central American Amerindians: new B*39 and B*51 alleles in the Kuna of Panama. Tissue Antigens 1997; 50: 251–257.
- 49 Tamouza R, Visser CJT, EI Kassar N, Poirier JC, Toubert A, Bierling P, Raffoux C, Charron D: Identification of a novel HLA-B*51 variant: HLA-B*5112. Tissue Antigens 1998; 52: 489–491.
- 50 Scott I, Dunn PPJ, Day S, Pesoa S, Little A-M, Madrigal JA, Vullo C: A novel HLA allele, HLA-B*5113, identified in the Kolla Amerindians of North-West Argentina. Tissue Antigens 1999; 53: 194–197.
- 51 Lee KW, Steiner N, Hurley CK: Sequence of an HLA-B56 variant (B*5604) identified in the Korean Population. Tissue Antigens 1998; 51: 210–212.
- 52 Grundschober C, Labonne M-P, Javaux F, Steiner Q-G, Gebuhrer L, Tiercy J-M: Sequence of four new HLA-Cw alleles: A possible role of interallelic recombination. Tissue Antigens 1998; 51: 72–79.
- 53 Turner S, Ellexson ME, Hickman HD, Side-bottom DA, Fernández-Viña M, Confer DL, Hildebrand WH: Sequence-based typing provides a new look at HLA-C diversity. J Immunol 1998; 161: 1406–1413.
- 54 Ren EC, Haniff F, Loh MT, Chan SH, Petersdorf E, Hansen J: Identification of a novel HLA-C allele, Cw*0406 in a Singapore Malay. Tissue Antigens 1999; 53: 198–200.
- 55 Baurain J-F, Coulie PG: Correction of HLA-Cw*0501 and identification of HLA-Cw*711. Tissue Antigens, in press.
- 56 Dunn PJ, Day S, Harvey J, Fuggle SV, Ross J: Identification of an HLA-C variant allele, Cw*0805, by sequencing based typing. Tissue Antigens 1998; 52: 587–589.
- 57 Vilches C, Bunce M, van Dam M, de Pablo R: A new pair of HLA-C alleles, Cw*12042 and Cw*1203, differing at the KIR-related dimorphism of codons 77-80. Tissue Antigens 1998; 51: 101–105.
- 58 Sanz L, Beraun Y, Nieto A, Martin J, Vilches C, de Pablo R: A new HLA-Cw*15 allele, Cw*1508, identified in the Peruvian population. Tissue Antigens, in press.
- 59 Steffensen R, Christiansen OB, Bennett EP, Jerslid C: HLA-E polymorphism in patients with recurrent sponaneous abortions. Tissue Antigens 1998; 52: 569–572.
- 60 Ober C, Rosinsky B, Grimsley C, van der Ven K, Robertson A, Runje A: Population genetic studies of HLA-G: Allele frequencies and linkage disequilibrium with HLA-A. J. Reprod Immunol 1996; 32: 111–123.
- 61 Kirzenbaum M, Djoulah S, Hors J, Legall I, de Oliveira EB, Prost S, Dausset J, Carosella E: HLA-G gene polymorphism segregation within CEPH reference families. Hum Immunol 1997; 53: 140–147.
- 62 Palou E, Arias MT, Isart F, Suárez B, Masso M, Fabregat V, Martorell J, Gayá A: Identification of a novel DRBI-allele (DRB1*0106) by sequence based typing. Tissue Antigens 1999; 53: 308–310.
- 63 Hashemi-Tavoularis S, Ouellet S, Sengar DPS, Buyse IM: A novel DRB3 allele (DRB3*0208), a new allelic variant of DRB1*1502 (DRB1*15023) and two new DQB1 (DQB1*03012 and DQB1*0614) alleles. Tissue Antigens 1998; 52: 294–299.
- 64 Buyse IM, Ouellet S, Hashemi-Tavoularis S: Identification of novel DRB1*13 (DRB1*1333), DRB1*04 (DRB1*0426) and DRB5* (DRB1*0109) alleles. Tissue Antigens 1998; 51: 658–665.
- 65 Bettens F, Kervaire B, Tiercy J-M: Sequence of HLA-DRB1*0431 allele. Tissue Antigens, in press.
- 66 Balas A, Santos S, Garcia-Sanchez F, Garcia-Escribano C, Merino JL, Vicario JL: Identification by polymerase chain reaction and sequencing-specific oligonucleotide and complete exon-2 cDNA sequencing of a new DRB1 (DRB1*1131) allele. Tissue Antigens 1997; 50: 96–98.
- 67 Loiseau P, Loste MN, Lepage V, Schaeffer V, Lethielleux P, Tilanus M, van Der Zwan AW, Dubel L, Nigou M, Johanet C, Charron D: Description of a new DRB1*11 allele (DRB1*1132). Tissue Antigens 1998; 52: 402–404.
- 68 Maeng C-Y, Kim KH, Kang JH, Han H, Kim KL: A novel HLA-DR12 allele (DRB1*1206) found in a Korean B-cell line. Tissue Antigens, in press.
- 69 Hashemi-Tavoularis S, Ouellet S, Buyse IM: Identification of new DRB1*07 (DRB1*0703), DRB1*08 (DRB1*0817) and two DRB3 (DRB3*0302 and DRB3*01014) alleles. Tissue Antigens 1998; 51: 577–581.
- 70 Buyse IM, Ouellet S, Hashemi-Tavoularis S: Sequence of DRB1*08031 is incorrect. Tissue Antigens 1998; 51: 676–677.
- 71 Kervaire B, Tiercy J-M: Sequence of HLA-DRB1*0818 in bone marrow donor. Eur J Immunogenet 1998; 24: 431–433.
- 72 Voorter CEM, Hentges F, van den Berg-Loonen EM: Identification of a new DRB3*02 allele (DRB3*0207) by sequence-based typing. Tissue Antigens 1997; 50: 552–554.
- 73 Naruse TK, Andoh R, Nose Y, Kagiya M, Ando H, Kawata H, Nabeya N, Isshiki G, Inoko H: HLA-DRB4 genotyping by PCR-RFLP: Diversity in the associations between HLA-DRB4 and DRB1 alleles. Tissue Antigens 1997; 49: 152–157.
- 74 Voorter CEM, Roeffaers HET, du Toit ED, van den Berg-Loonen EM: The absence of DR51 in a DRB5-positive individual DR2ES is caused by a null allele (DRB5*0108N). Tissue Antigens 1997; 50: 326–333.
- 75 Trejaut JA, Greville WD, Dunckley H: DQA1 subtyping in Australian Aborigines. Additional evidence for heterogeneity.
- 76 Schranz P, Albert ED, Renz M, Seelig R, Seelig HP: Nucleotide sequence of a new HLA DQA1*06 allele (DQA1*06012). Tissue Antigens 1997; 50: 693–694.
- 77 White JM, Baxter-Lowe L-A: Nucleotide sequencing reveals a novel DQB1-06 allele (DQB1*06013) with a silent mutation at codon 137. Tissue Antigens 1998; 52: 196–198.
- 78 Hsu SH, Robbins FM, Modelo RB, Brunner J, Flomenberg N: Identification of a new DQB1*0613 allele in a family. Tissue Antigens 1997; 50: 685–687.
- 79 Trowsdale J, Kelly A: The human HLA class II α chain gene DZα is distinct from genes in the DP, DQ and DR subregions. EMBO J 1985; 4: 2231–2237.
- 80 Naruse TK, Kawata H, Anzai T, Takashige N, Kagiya M, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Inoko H: Limited polymorphism in the HLA-DOA gene. Tissue Antigens, in press.
- 81 Jonsson A-K, Rask L: Human class II DNA and DOB gens display low sequence variability. Immunogenetics 1989; 29: 411–413.
- 82 Young JAT, Trowsdale J: The HLA-DNA (DZA) gene is correctly expressed as a 1.1-kb mature mRNA transcript. Immunogenetics 1990; 31: 386–388.
- 83 Steiner LL, Wu J, Noreen HJ, Moehlenkamp C, Cavalli A, Davidson M, Johnson S, Winden T, Segall M, Begovich AB, Williams TM: Four new DP alleles identified in a study of 500 unrelated bone marrow donor-recipient pairs. Tissu Antigens 1999; 53: 201–206.
- 84 Steiner LL, Cavalli A, Zimmerman PA, Boatin BA, Titanji VPK, Bradley JE, Lucius R, Nutman TB, Begovich AB: Three new DP alleles identified in sub-Saharan Africa: DPB1*7401, DPA1*02013 and DPA1*0302. Tissue Antigens 1998; 51: 653–662.
- 85 Rozemuller EH, Allebes WA, van den Berg-Loonen EP, Hidajat M, Gordijn A-W, Tilanus MGJ, Joosten I: DPB1*7601, a novel DPB1 variant in the Caucasoid population. Tissue Antigens 1998; 51: 663–665.
- 86 Voorter C, Richeldi L, Gervais T, van den Berg-Loonen E: Identification of two new DPB1 alleles, DPB1*7701 and *7801 by sequence based typing. Tissue Antigens 1998; 52: 190–192.
- 87 Voorter C, Chatelain B, Sintnicolaas K, Tilanus M, Hidajat M, van den Berg-Loonen E: Identification of a new DPB1 allele (DPB1*7901) by sequence based typing. Tissue Antigens 1998; 52: 193–195.
- 88 Fodil N, Laloux L, Wanner V, Pellet P, Hauptmann G, Mizuki N, Inoko H, Spies T, Theodorou I, Bahram S: Allelic repertoire of the human MHC clas*** I MICA gene. Immunogenetics 1996; 1996: 351–357.
- 89 Gaudieri S, Leelayuwat C, Townend DC, Mullberg J, Cosman D, Dawkins RL: Allelic and interlocus comparison of the PERB11 multigene family in the MHC. Immunogenetics 1997; 45: 209–216.
- 90 Bahram S, Mizuki N, Inoko H, Spies T: Nucleotide sequence of the human MHC class I MICA gene. Immunogenetics 1996; 44: 80–81.
Citing Literature
